Publication
Implantable devices can be developed for the simultaneous monitoring of a specific group of key metabolites, identified by more complex techniques, such as mass spectroscopy- or nuclear magnetic -based analysis.. Since there is a strong correlation between metabolite concentration in the blood and in the extracellular space, often it is more convenient to locate the implant into the subcutaneous tissues, to avoid coagulation problems and long-term pharmacological therapies.